ANDREA LYONNAIS: Open Payments
NPI 1184737512 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 13 payments from 8 companies in 2025. Trend: 2023 $137 · 2024 $323 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Eisai Inc. | 1 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Verona Pharma, Inc. | 1 | $21 |
Products named: LEQVIO, QULIPTA, Leqembi, ONPATTRO, UBRELVY, JARDIANCE, INSPIRE, Ohtuvayre.
Industry payments across MA — which companies pay providers there.
